HU179141B - - Google Patents

Info

Publication number
HU179141B
HU179141B HU77CI1770A HUCI001770A HU179141B HU 179141 B HU179141 B HU 179141B HU 77CI1770 A HU77CI1770 A HU 77CI1770A HU CI001770 A HUCI001770 A HU CI001770A HU 179141 B HU179141 B HU 179141B
Authority
HU
Hungary
Application number
HU77CI1770A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to HU77CI1770A priority Critical patent/HU179141B/hu
Priority to IL55569A priority patent/IL55569A/xx
Priority to GR57216A priority patent/GR65001B/el
Priority to DE19782840142 priority patent/DE2840142A1/de
Priority to CS786036A priority patent/CS200242B2/cs
Priority to IT69160/78A priority patent/IT1160661B/it
Priority to YU02206/78A priority patent/YU220678A/xx
Priority to AT0677478A priority patent/AT369362B/de
Priority to SE7809946A priority patent/SE447574B/sv
Priority to FI782878A priority patent/FI65912C/fi
Priority to BE190613A priority patent/BE870646A/xx
Priority to DD78208003A priority patent/DD138600A5/xx
Priority to FR7827079A priority patent/FR2404006A1/fr
Priority to DK420778A priority patent/DK420778A/da
Priority to GB7837834A priority patent/GB2006193B/en
Priority to CH995078A priority patent/CH637388A5/de
Priority to PL1978209773A priority patent/PL121664B1/pl
Priority to JP11738378A priority patent/JPS5456685A/ja
Priority to NL7809643A priority patent/NL7809643A/xx
Priority to SU782668853A priority patent/SU847914A3/ru
Publication of HU179141B publication Critical patent/HU179141B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU77CI1770A 1977-09-23 1977-09-23 HU179141B (en:Method)

Priority Applications (20)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (en:Method) 1977-09-23 1977-09-23
IL55569A IL55569A (en) 1977-09-23 1978-09-13 Inclusion complexes of prostacyclin,or a derivative thereof,with cyclodextrins,their preparation and pharmaceutical compositions containing them
GR57216A GR65001B (en) 1977-09-23 1978-09-13 Method for the preparation of complexes of prostacycline occlusion and derivatives of prostacycline with cyclodextrines
DE19782840142 DE2840142A1 (de) 1977-09-23 1978-09-15 Die mit cyclodextrin gebildeten einschlusskomplexe des prostacyclins und seiner derivate sowie verfahren zur herstellung dieser komplexe
CS786036A CS200242B2 (en) 1977-09-23 1978-09-18 Process for preparing inclusion complexes of derivatives prostacycline with beta-cyclodextrine
IT69160/78A IT1160661B (it) 1977-09-23 1978-09-19 Complessi di inclusione di prostaciclina e derivati di prostaciclina con ciclodestrine e procedimento per la loro preparazione
YU02206/78A YU220678A (en) 1977-09-23 1978-09-19 Process for obtaining inclusion complexes of cyclodextrin with prostacycline
AT0677478A AT369362B (de) 1977-09-23 1978-09-20 Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten
SE7809946A SE447574B (sv) 1977-09-23 1978-09-21 Inklusionskomplex av prostacyklin-metylester och beta-cyklodextrin, sett for dess framstellning samt lekemedelsberedning baserad derpa
FI782878A FI65912C (fi) 1977-09-23 1978-09-21 Foerfarande foer framstaellning av farmaceutiskt anvaendbara inklusionskomplexer av prostacyklin och prostacyklin-c1-4-estrar med beta-cyklodextrin
BE190613A BE870646A (fr) 1977-09-23 1978-09-21 Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments
DD78208003A DD138600A5 (de) 1977-09-23 1978-09-21 Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes
FR7827079A FR2404006A1 (fr) 1977-09-23 1978-09-21 Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments
DK420778A DK420778A (da) 1977-09-23 1978-09-22 Inklusionskomplekser af prostacyclin og prostacyclinderivatermed cyclodextriner samt deres fremstilling og anvendelse
GB7837834A GB2006193B (en) 1977-09-23 1978-09-22 Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them
CH995078A CH637388A5 (de) 1977-09-23 1978-09-22 Die mit cyclodextrin gebildeten einschlusskomplexe des prostacyclins und seiner ester sowie verfahren zur herstellung dieser komplexe.
PL1978209773A PL121664B1 (en) 1977-09-23 1978-09-22 Process for preparing inclusion compounds of prostacycline and its esters with alkyls of 1 to 4 carbon atoms with cyclodextrinsna i ego alkilovykh ehfirov s 1-4 atomami uglja s ciklogekstrinami
JP11738378A JPS5456685A (en) 1977-09-23 1978-09-22 Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same
NL7809643A NL7809643A (nl) 1977-09-23 1978-09-22 Werkwijzen voor het bereiden van insluitingscomplexen en van geneesmiddelen die deze complexen bevatten.
SU782668853A SU847914A3 (ru) 1977-09-23 1978-09-22 Способ получени комплексов включени С -циКлОдЕКСТРиНОМ пРОизВОдНыХ пРОСТАциКлиНОВ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (en:Method) 1977-09-23 1977-09-23

Publications (1)

Publication Number Publication Date
HU179141B true HU179141B (en:Method) 1982-08-28

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
HU77CI1770A HU179141B (en:Method) 1977-09-23 1977-09-23

Country Status (20)

Country Link
JP (1) JPS5456685A (en:Method)
AT (1) AT369362B (en:Method)
BE (1) BE870646A (en:Method)
CH (1) CH637388A5 (en:Method)
CS (1) CS200242B2 (en:Method)
DD (1) DD138600A5 (en:Method)
DE (1) DE2840142A1 (en:Method)
DK (1) DK420778A (en:Method)
FI (1) FI65912C (en:Method)
FR (1) FR2404006A1 (en:Method)
GB (1) GB2006193B (en:Method)
GR (1) GR65001B (en:Method)
HU (1) HU179141B (en:Method)
IL (1) IL55569A (en:Method)
IT (1) IT1160661B (en:Method)
NL (1) NL7809643A (en:Method)
PL (1) PL121664B1 (en:Method)
SE (1) SE447574B (en:Method)
SU (1) SU847914A3 (en:Method)
YU (1) YU220678A (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
KR20060127946A (ko) 2004-01-29 2006-12-13 에자이 알앤드디 매니지먼트 가부시키가이샤 매크롤라이드계 화합물의 안정화 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (en:Method) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
DK420778A (da) 1979-03-24
IT7869160A0 (it) 1978-09-19
JPS5456685A (en) 1979-05-07
DE2840142A1 (de) 1979-04-05
IL55569A (en) 1981-12-31
IT1160661B (it) 1987-03-11
SE447574B (sv) 1986-11-24
YU220678A (en) 1983-10-31
PL209773A1 (pl) 1979-06-04
FR2404006A1 (fr) 1979-04-20
GR65001B (en) 1980-06-12
AT369362B (de) 1982-12-27
IL55569A0 (en) 1978-12-17
SU847914A3 (ru) 1981-07-15
FI65912B (fi) 1984-04-30
GB2006193A (en) 1979-05-02
NL7809643A (nl) 1979-03-27
BE870646A (fr) 1979-01-15
GB2006193B (en) 1982-05-26
FR2404006B1 (en:Method) 1981-07-31
CH637388A5 (de) 1983-07-29
DD138600A5 (de) 1979-11-14
FI782878A7 (fi) 1979-03-24
CS200242B2 (en) 1980-08-29
FI65912C (fi) 1984-08-10
PL121664B1 (en) 1982-05-31
ATA677478A (de) 1982-05-15
SE7809946L (sv) 1979-03-24

Similar Documents

Publication Publication Date Title
FR2377587B1 (en:Method)
FR2379118B1 (en:Method)
FR2378329B3 (en:Method)
FR2376531B1 (en:Method)
FR2376722B1 (en:Method)
FR2376823B1 (en:Method)
FR2377156B1 (en:Method)
FR2404006B1 (en:Method)
FR2377191B1 (en:Method)
FR2378797B1 (en:Method)
CH631858GA3 (en:Method)
CH650893GA3 (en:Method)
BE872973A (en:Method)
BG26213A1 (en:Method)
BG25823A1 (en:Method)
BG25852A1 (en:Method)
BG25822A1 (en:Method)
BG25820A1 (en:Method)
BG25819A1 (en:Method)
BG25815A1 (en:Method)
BG25813A1 (en:Method)
BG25812A1 (en:Method)
BG25825A1 (en:Method)
BG25811A1 (en:Method)
BG25829A1 (en:Method)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee